AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma

SIMPLE SUMMARY: Bcl-2 family proteins play a key role in myeloma cell survival and are implicated in drug resistance and development of refractory disease, thus making them an attractive therapeutic target. Currently available strategies targeting Bcl-2 proteins in multiple myeloma have shown a bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Ailawadhi, Sikander, Parrondo, Ricardo D., Dutta, Navnita, Han, Bing, Ciccio, Gina, Cherukuri, Yesesri, Alegria, Victoria R., LaPlant, Betsy R., Roy, Vivek, Sher, Taimur, Edwards, Brett, Lanier, Stephanie, Manna, Alak, Heslop, Keisha, Caulfield, Thomas, Maldosevic, Emir, Storz, Peter, Manochakian, Rami, Asmann, Yan, Chanan-Khan, Asher A., Paulus, Aneel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857228/
https://www.ncbi.nlm.nih.gov/pubmed/36672426
http://dx.doi.org/10.3390/cancers15020477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857228/
https://www.ncbi.nlm.nih.gov/pubmed/36672426
http://dx.doi.org/10.3390/cancers15020477

Ejemplares similares